Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
Yongxian HuBone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. [email protected]Yali ZhouDepartment of Hematology, Ruian people's Hospital, Wenzhou, Zhejiang, ChinaMingming ZhangInstitute of Hematology, Zhejiang University, Hangzhou, Zhejiang, ChinaHouli ZhaoBone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaGuoqing WeiBone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaWengang GeQu CuiDepartment of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaQitian MuLaboratory of Stem Cell Transplantation, Ningbo First Hospital, Ningbo, Zhejiang, ChinaGong ChenLu HanTingting GuoJiazhen CuiBone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaXiaoyan JiangXiujun ZhengShuhui YuXiaolong LiXingwang ZhangMingxi ChenXiuju LiMing GaoKang WangCheng ZuInstitute of Hematology, Zhejiang University, Hangzhou, Zhejiang, ChinaHao ZhangRuian People's HospitalXiaohong HeYanbin WangDongrui WangZhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, Zhejiang, China. [email protected]Jiangtao RenNanjing Bioheng Biotech Co., Ltd, Nanjing, Jiangsu, China. [email protected]He HuangBone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. [email protected]
2022en
Ochiq kirishBronza
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba